Indaptus Therapeutics Inc [NASDAQ: INDP] jumped around 412479.73 points on Monday, while shares priced at $412480.0 at the close of the session, up 364441001%.
Indaptus Therapeutics Inc stock is now -79.92% down from its year-to-date (YTD) trading value. INDP Stock saw the intraday high of $0.7112 and lowest of $0.4726 per share. The company’s 52-week high price is 2.42, which means current price is +85.12% above from all time high which was touched on 03/18/25.
Compared to the average trading volume of 412.48K shares, INDP reached a trading volume of 364441001 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Indaptus Therapeutics Inc [INDP]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for INDP shares is $2.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on INDP stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
The Price to Book ratio for the last quarter was 2.86, with the Price to Cash per share for the same quarter was set at 0.24.
How has INDP stock performed recently?
Indaptus Therapeutics Inc [INDP] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 53.94. With this latest performance, INDP shares gained by 31.58% in over the last four-week period, additionally sinking by -44.99% over the last 6 months – not to mention a drop of -40.62% in the past year of trading.
Indaptus Therapeutics Inc [INDP]: Deeper insight into the fundamentals
Return on Equity for this stock declined to -192.51%, with Return on Assets sitting at -192.51%.
Earnings analysis for Indaptus Therapeutics Inc [INDP]
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for INDP. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Indaptus Therapeutics Inc go to 18.55%.
Insider trade positions for Indaptus Therapeutics Inc [INDP]
There are presently around $13.08%, or 20.73%% of INDP stock, in the hands of institutional investors. The top three institutional holders of INDP stocks are: VANGUARD GROUP INC with ownership of 0.26 million shares, which is approximately 3.0355%. INVESTMENT HOUSE LLC, holding 0.1 million shares of the stock with an approximate value of $$0.22 million in INDP stocks shares; and INVESTMENT HOUSE LLC, currently with $$0.13 million in INDP stock with ownership which is approximately 0.7025%.
